戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  patient presenting with aggressive pyoderma gangrenosum.
2 confirmed the clinical suspicion of pyoderma gangrenosum.
3 included pathergy, cystic acne, and pyoderma gangrenosum.
4 e discussed regarding psoriasis and pyoderma gangrenosum.
5 cers with a clinical resemblance to pyoderma gangrenosum.
6  and pretibial lesions diagnosed as pyoderma gangrenosum.
7 itides such as Sweet's syndrome and pyoderma gangrenosum.
8 al item deletion (Erythema nodosum, Pyoderma gangrenosum), a 7-item scale was estimated.
9 ing of a disease locus for familial pyoderma gangrenosum-acne-arthritis to the long arm of chromosome
10 l wall lesions were suspected to be pyoderma gangrenosum although biopsies were equivocal.
11 h cutaneous manifestations, such as pyoderma gangrenosum and acne fulminans, predominated.
12  and less frequently accompanied by pyoderma gangrenosum and acne.
13 mmatory disease; pyogenic arthritis pyoderma gangrenosum and acne; Muckle-Wells syndrome; familial co
14 ents with Sweet's syndrome (SW) and pyoderma gangrenosum and found numerous novel splice variants in
15 n tissue samples from patients with pyoderma gangrenosum and healthy controls.
16 s of PSTPIP1 in the pathogenesis of pyoderma gangrenosum and suggest that the cytoskeleton is a ratio
17  case of CB, initially diagnosed as pyoderma gangrenosum and treated with steroids, leading to dissem
18         Pyogenic sterile arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome (OMIM 604416) is a
19  disease called pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome.
20 the syndrome of pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA), a dominantly inherited aut
21                 Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne Syndrome (PAPA syndrome) is an aut
22 n (MRST); and a pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA).
23 ome and pyogenic sterile arthritis, pyoderma gangrenosum, and acne syndrome.
24 ndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne, OMIM #604416) and familial recurr
25 ndrome: pyogenic sterile arthritis, pyoderma gangrenosum, and acne.
26  with Sweet syndrome, patients with pyoderma gangrenosum, and healthy controls.
27 aneous spread, clinically mimicking pyoderma gangrenosum, and subsequently progressed to disseminated
28 57 consecutive patients treated for pyoderma gangrenosum at our institution (10 percent).
29 associated disease and suggest that pyoderma gangrenosum can be classified as a dynamical disease at
30  exclusion, and the misdiagnosis of pyoderma gangrenosum can result in substantial complications in p
31                                     Pyoderma gangrenosum, cystic acne, and aseptic arthritis are clin
32 er entities, CB may be mistaken for pyoderma gangrenosum due to overlap of findings on histopathologi
33 ts studied, 64 had been treated for pyoderma gangrenosum for a median of 10 months (range, 3 to 180).
34 utive patients treated for presumed pyoderma gangrenosum from 1984 through 1992.
35 enosum (PPG), an unusual variant of pyoderma gangrenosum, has been reported almost exclusively in pat
36    Here we report the first case of pyoderma gangrenosum in a patient with refractory celiac disease.
37 in all patients suspected of having pyoderma gangrenosum in order to rule out alternative diagnoses.
38                                     Pyoderma gangrenosum is a diagnosis of exclusion, and the misdiag
39                                     Pyoderma gangrenosum is an inflammatory neutrophilic dermatosis c
40                                     Pyoderma gangrenosum is associated with a concomitant systemic di
41                 The misdiagnosis of pyoderma gangrenosum is not uncommon and exposes patients to risk
42 cers in the 64 patients treated for pyoderma gangrenosum, it was clear that those in 23 patients (36
43  that refractory celiac disease and pyoderma gangrenosum may be immunologically different.
44 d in all other patients with either pyoderma gangrenosum or SW, it was always associated with splice
45                                   A pyoderma gangrenosum patient exhibiting aberrant leukocyte traffi
46 determining patient eligibility for pyoderma gangrenosum (PG) clinical trials.
47                                     Pyoderma Gangrenosum (PG) is a cutaneous condition, its diagnosis
48                                     Pyoderma gangrenosum (PG) is a neutrophilic dermatosis of unclear
49                                     Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis that
50                                     Pyoderma gangrenosum (PG) is an important disease with significan
51                                     Pyoderma gangrenosum (PG) is an inflammatory condition characteri
52    Unlike erythema nodosum (EN) and pyoderma gangrenosum (PG), LCV requires biopsy for diagnosis.
53                          Peristomal pyoderma gangrenosum (PPG), an unusual variant of pyoderma gangre
54 er neutrophilic dermatoses, such as pyoderma gangrenosum, remain poorly understood.
55 ot respond to treatment directed at pyoderma gangrenosum, those in 8 (12 percent) were exacerbated by
56                  Good resolution of pyoderma gangrenosum was achieved in 3 patients with tumor necros
57 of 240 patients with a diagnosis of pyoderma gangrenosum who were evaluated at our institution from 1
58 y occurring, extra-hepatic onset of pyoderma gangrenosum, with the AIH in remission, strengthening th